Everolimus for subependymal giant cell astrocytoma: 5‐year final analysis

OBJECTIVE: To analyze the cumulative efficacy and safety of everolimus in treating subependymal giant cell astrocytomas (SEGA) associated with tuberous sclerosis complex (TSC) from an open‐label phase II study (NCT00411619). Updated data became available from the conclusion of the extension phase an...

Descripción completa

Detalles Bibliográficos
Autores principales: Franz, David N., Agricola, Karen, Mays, Maxwell, Tudor, Cindy, Care, Marguerite M., Holland‐Bouley, Katherine, Berkowitz, Noah, Miao, Sara, Peyrard, Séverine, Krueger, Darcy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063160/
https://www.ncbi.nlm.nih.gov/pubmed/26381530
http://dx.doi.org/10.1002/ana.24523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063160/
https://www.ncbi.nlm.nih.gov/pubmed/26381530
http://dx.doi.org/10.1002/ana.24523

Ejemplares similares